Post Myocardial Infarction

Updated: July 12, 2024

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

atenolol

100

Orally

once a day

ticagrelor

Loading dose (following ACS event): 180 mg orally, single dose
The maintenance dose (for 1st 12 months after diagnosis): 90 mg orally two times
The maintenance dose (after 12 months from diagnosis): 60 mg orally two times
Also, continue with aspirin 75-100 mg

eplerenone

Orally 

every day

valsartan

May begin as soon as 12 hours after MI
20 mg orally 2 times a day
may increase to 40 mg orally 2 times a day after 7 days
with successive titrations to the goal maintenance dosage of 160 mg twice a day as tolerated

molsidomine

(heart failure):

2 to 4 mg Intravenously given as a single dosage; 2 mg can be repeated at time intervals of minimum 2 hours if required. Maximum dose: 40 mg per day. Infusions can be employed at a rate of 3 mg/hr

Future Trends